Regional Innovation to Reach the MarketBy Miriam Bello | Wed, 04/27/2022 - 11:45
Experts meet at innovation events to expose how to adapt, create and share novel developments in healthcare. These efforts call for a multisectoral approach and collaboration to the benefit of the population.
Here is the Week in Health!
AMIIF’s Innovation Week 2022 was inaugurated this week at Papalote Children's Museum. This year’s goal is recognizing the transformation of the health sector and the contributions of the pharmaceutical industry. The event also aims to showcase the lessons learnt by the biopharmaceutical sector to improve collaboration with industry, society and governments. Learn more about the event here.
LATAM Healthcare Innovation Summit 2022 took place last week to discuss how innovation and technology must go beyond adoption and center on the patient to push providers to create their own solutions. The event, organized by the Bamber Foundation, hosted representatives from some of the largest health players of the industry in Mexico, including Christus Muguerza, Médica Sur and Centro Médico ABC.
Deputy Minister of Health Hugo López-Gatell announced that children between the ages of 12 and 17 can register for the COVID-19 vaccine starting on April 28, 2022. The move comes after the Pfizer-BioNTech vaccine was approved for children between five to 11 years old in emergency cases.
The Pan American Health Organization (PAHO) will celebrate both the Vaccination Week in the Americas (VWA) and the World Immunization Week (WIW), events that aim to raise awareness on the importance of vaccinating people of all ages against preventable diseases.
IMSS and CONACYT just signed an agreement to develop biomedical technology and support scientific research. This collaboration will boost the development of vaccines, biopharmaceutical products and medical devices for IMSS’s healthcare centers. The project is designed to strengthen scientific and technological sovereignty within the health system.
Mexico’s Chamber of Deputies approved changes to the General Health Law pertaining to mental health and addiction. The law also aims to eliminate psychiatric hospitals and standardize the rules to intern psychiatric patients in care centers. The reform, according to the Human Rights Commission of Mexico City (CDHCM), lays the foundations to establish mental health and addiction prevention as priority axes within public health.
While lithium has been in the spotlight for its role in the production of EVs batteries, it also plays an essential role in the treatment of mental health diseases such as dementia and bipolar disorder. Lithium salts have long been used to treat the mania phase of bipolar disorder and researchers keep finding new applications in the treatment of other mental diseases.
Although malaria is a preventable and curable disease, 627,000 people died from it worldwide in 2020. In Mexico, mortality from malaria is low. In 2020, Chiapas, Chihuahua, Sinaloa, Tabasco and Campeche reported malaria cases but the following year, the country saw less than 100 new cases. During the past 10 years, 24 states including Mexico City, have not reported any malaria case and are thus considered to be malaria-free.
A recent study of thousands of tumors has revealed the possibility to detect mutational signatures in the DNA of cancers, enabling physicians to determine whether a patient has had past exposure to environmental causes of cancer such as smoking or UV light.
Transformed by digitization, the health sector needs new competences and careers that will respond to tech services and solutions for direct-to-patient contact and institutional performance.
Beyond economies and supply chains, the COVID-19 pandemic also impacted mental and physical health. The feeling of loneliness worsened during the past two years as individuals isolated during the pandemic, affecting both body and brain, explain experts.
Experts of the Week
- Ron Volpe, Senior Vice President International Markets, PSQR
- Raúl Rodríguez, CEO, Ocean Medic
- Mario Muniz, General Manager North LATAM Region, IQVIA
- Rafael Gual, Director General, CANIFARMA